Mature T/NK-cell lymphomas are a group of hematological malignancies characterized by the proliferation of mature T or natural killer (NK) cells. The unspecified nature of the lymphomas in this code indicates a lack of specific subtype classification. This condition primarily affects lymph nodes in the inguinal region and lower limb, leading to significant clinical implications such as lymphadenopathy and potential systemic symptoms. Accurate coding with ICD-10 Code C84.95 is essential for proper diagnosis, documentation, medical billing, and public health reporting.
ICD-10 Code C84.95 represents mature T/NK-cell lymphomas that are unspecified and localized to the inguinal region and lower limb lymph nodes. This code is used when the specific subtype of T/NK-cell lymphoma is not identified. It is crucial for clinical documentation and billing to ensure accurate representation of the patient's condition, particularly in cases where lymphadenopathy is present without a defined etiology.
Mature T/NK-cell lymphomas are aggressive malignancies that arise from mature T or NK cells. The unspecified nature of this code indicates that the specific subtype has not been determined, which can complicate treatment and prognosis. These lymphomas can progress rapidly and require prompt medical intervention.
In clinical workflows, ICD-10 Code C84.95 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management.
ICD-10 Code C84.95 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of mature T/NK-cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of mature T/NK-cell lymphomas requires urgent medical attention due to their aggressive nature. Treatment strategies may include chemotherapy, targeted therapy, and supportive care.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.95 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, single or initial substance. |
| 99223 | Initial hospital care, typically 70 minutes or more of total time on the date of the encounter. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymphatic system, including lymphangiography. |
Common Questions About Using ICD-10 Code C84.95 for Mature T/NK-cell lymph, unsp, nodes of ing rgn and low limb
What are the common symptoms of mature T/NK-cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may also experience localized pain or discomfort in affected areas.
How is mature T/NK-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes. Histopathological analysis is essential for confirming the diagnosis.
What treatment options are available for this condition?
Treatment may include chemotherapy, targeted therapy, and supportive care. The specific regimen depends on the lymphoma subtype and the patient's overall health.
Is hospitalization required for patients with this diagnosis?
Hospitalization may be necessary for patients requiring intensive treatment, management of complications, or those with severe symptoms. Close monitoring is essential during treatment.
Clinical Notes
SOAP notes
DAP notes
AI medical notes